Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-001042-28Phase 4
Phase 4, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Hour 4 Permanent Product Math Test Attempted Score (PERMP-Attempted).
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-001042-28.